Trials / Conditions / Neuroendocrine Tumor Grade 3

Neuroendocrine Tumor Grade 3

3 registered clinical trials studyying Neuroendocrine Tumor Grade 3.

Status	Trial	Sponsor	Phase
Unknown	Surufatinib in G3 Neuroendocrine Tumors NCT05973968	Qilu Hospital of Shandong University	—
Unknown	Multi-cohort Study of Surufatinib Plus Sintilimab in Metastatic NEN and Pancreatic Carcinoma Who Failed Standa NCT05627427	Tianjin Medical University Cancer Institute and Hospital	Phase 2
Unknown	Chidamide Plus Sintilimab for Chemotherapy-refractory Advanced High-grade Neuroendocrine Neoplasm NCT05113355	Peking Union Medical College Hospital	Phase 2